Business Process Outsourcing
PRODUCTS
-
Gibco™ High-temperature, short-time (HTST) treatment of raw materials
HTST treatment currently available in North America
Simple sugar batch sizes ranging from 800 to 8,800 L
In-house HTST preparation can be expensive and cumbersome. Outsourcing this technology to Thermo Fisher Scientific can alleviate production bottlenecks and increase viral mitigation confidence.
Suitable and cost-effective for large volumes
Standard and custom bioprocessing containers available (5 L–1,000 L). Please contact your sales representative.
-
Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Regulator (OGTR).
-
The Class 2, Type B2 Laminar Flow Biosafety Cabinet provides a high degree of localized protection from particulate and aerosol hazards. The work area is continuously bathed with laminar flow ISO 5/Class 100 HEPA-filtered air while creating a negative pressure airflow into the cabinet to provide user protection.
-
Why Patient Recruitment Matters in Clinical Research
Patient recruitment is one of the most critical aspects of a clinical trial’s success. Without an adequate and diverse participant pool, trials risk failing to generate reliable and representative data. Ensuring sufficient participation is essential for producing statistically valid results that confirm the treatment's safety and effectiveness.
For biotech companies, especially those under tight timelines and budgets, partnering with an experienced CRO like Novotech ensures that patient recruitment efforts are both efficient and effective, enabling timely trial completion and robust data collection.
-
In such a highly regulated environment, change is not undertaken lightly. As a result, a lack of internal resources can often obstruct the implementation of change.
WHITE PAPERS AND CASE STUDIES
-
Revolutionizing Particle Characterization With Image Analysis And ML
The biopharmaceutical industry is increasingly employing micro-flow imaging for particle characterization, owing to the superior insights it can afford into product quality and process controls.
-
CRO Collaboration That Fuels Innovation For Specialty Biotechs
Delve into the advantages of specialty CRO collaborations and the strategic opportunities that lie ahead as the life sciences field continues to embrace innovation and collaboration.
-
How A Biotechnology Company Chose To Improve Their Data Management
Hear about a late-stage biotechnology company that wanted to harden its data infrastructure, end wide-scale use of Excel for data management, and accelerate data sharing among a large external network.
-
BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle Times
Learn about a collaboration that has enabled BioIVT to enhance efficiency and responsiveness to its biopharmaceutical clients.
-
Eliminating USP <88> In Vivo Animal Bioreactivity Testing For Polymer Characterization
There has been growing awareness about the environmental and ethical implications of plastics used in bioprocessing. The time for a shift to well-studied, proven in vitro cytotoxicity testing is now.
-
Reimagining FSP With ProPharma's RCO Model
Begin leveraging our Research Consulting Organization (RCO) model and gain access to customized, agile, and scalable solutions that continuously evolve to meet your unique needs.
-
Calculating Your Business Case For Continuous Manufacturing
Review key considerations as a Pharmatech Associates expert introduces a useful financial equation to calculate amortization to develop the business case for PCM and provides a few real-world cases.
-
Damper Maintenance Made Easy: ABB's Actuators Minimize Customer Plant Shutdowns
When a customer’s plant stopped working unexpectedly, the ABB team in Brazil stepped up to the challenge.
-
Reducing Costs & Risks: A Pharma Guide To FTZ Subzones For U.S. Drug Manufacturing
Utilized wisely, FTZs and subzones can be tools for cost savings and can enable pharma companies to leverage the benefits of American manufacturing.
-
Case Study: Connexin Is Taking The UK's 'Smart Cities' To The Next Level
With Skedulo, Connexin is streamlining processes via automation, increasing connectedness between their office & field teams, and elevating their customer experience.
-
Could RFID-Based Unit-Level Traceability Be Key To Operational Excellence?
Radiofrequency identification (RFID)-based unit-level tracking solutions for prefilled syringes are poised to help pharma manufacturers address key risks and costly bottlenecks related to the fill-finish process.
-
Overcoming HCP Co-Elution Issues Using Cell Line Engineering
Product quality assessments revealed that a customer’s therapeutic protein had a range of hydrophobic HCPs. Review a solution that took an alternative approach by utilizing cell line engineering.
NEWS
-
AI Speeding Discovery Of New Drugs8/6/2024
The human body contains at least 20,000 different proteins, often called the “workhorses of the cell” because of their role in keeping cells healthy.
-
Mitsubishi UFJ Capital And AGC Sign A Mandate Agreement For The Technical Evaluation Of Drug Manufacturing For Investment Activities In Drug Discovery Start-ups3/4/2025
Mitsubishi UFJ Capital Co., Ltd.(Mitsubishi UFJ Capital; President: Takuro Kojima, Headquarters: Tokyo)and AGC Inc. (AGC; President: Yoshinori Hirai, Headquarters: Tokyo)have signed a mandate agreement for the technical evaluation of drug manufacturing, as part of Mitsubishi UFJ Capital's investment activities in drug discovery startups, etc.
-
20 kW Laser System For Producing High Purity Crystals2/9/2024
High-purity semiconductor crystals are required for power electronics in electric cars or in photovoltaics. When such crystals reach a diameter of 2 inches, they become relevant for industrial applications.
-
SpringWorks Therapeutics Announces FDA Approval Of GOMEKLI™ (mirdametinib) For The Treatment Of Adult And Pediatric Patients With NF1-PN2/11/2025
SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, announced today that the U.S. Food and Drug Administration (FDA) has approved GOMEKLI™ (mirdametinib), SpringWorks’ MEK inhibitor, for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) not amenable to complete resection.1
-
LeakNavigator Delivers 80% Conversion Rate For Southern Water11/19/2024
The water company’s Water Resources Management Plan 2024 sets out long-term plans to more than halve leakage by 2050 through a combination of new technologies and enhanced monitoring, using tools such as acoustic sensors and digitalised management systems.